首页> 美国卫生研究院文献>Environmental Health Perspectives >Cell proliferation and carcinogenesis: a brief history and current view based on an IARC workshop report. International Agency for Research on Cancer.
【2h】

Cell proliferation and carcinogenesis: a brief history and current view based on an IARC workshop report. International Agency for Research on Cancer.

机译:细胞增殖和致癌作用:基于IARC研讨会报告的简短历史和当前观点。国际癌症研究机构。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The International Agency for Research on Cancer recently convened a Working Group of Experts (June 11-18, 1991) to discuss the use of information on carcinogenesis mechanisms in carcinogenic risk identification. The role of cell proliferation in carcinogenesis was among the items discussed in detail. It was recognized that cell proliferation is an important mechanistic aspect for both genotoxic and nongenotoxic carcinogens. It may act at each stage of the carcinogenesis process, altering the size of the pool of cells at risk for a next event. Cell proliferation was considered to be important, especially as a) an integral part of the process of converting DNA adducts to mutation, b) an enhancing factor for the mutation frequency by inducing errors in replication, and c) an important factor in determining dose-response relationships for some carcinogens. It was also recognized that not all agents that induce cell proliferation are necessarily involved in carcinogenesis; for example, a) not all skin hyperplasia-inducing compounds are skin tumor promoters, b) agents that induce "regenerative" cell proliferation appear to have different effects on tumor induction from agents that have a direct mitogenic effect, and c) the carcinogenic activity of many nonmutagenic agents depends on the continuous administration of the agent. In addition, tissues with a high rate of cell proliferation do not have a higher risk of developing cancer. Thus, no simple relationship exists between cell proliferation and carcinogenesis.
机译:国际癌症研究机构最近召集了一个专家工作组(1991年6月11日至18日),讨论在致癌风险识别中使用有关致癌机制的信息。细胞增殖在致癌作用中的作用已详细讨论。已经认识到,细胞增殖对于遗传毒性和非遗传毒性致癌物都是重要的机理方面。它可能在癌变过程的每个阶段起作用,从而改变有发生下一个事件风险的细胞池的大小。人们认为细胞增殖很重要,尤其是a)将DNA加合物转化为突变过程中不可或缺的部分,b)通过诱导复制错误来提高突变频率的增强因子,以及c)确定剂量的重要因素-某些致癌物的反应关系。还已经认识到,并不是所有诱导细胞增殖的试剂都必须参与致癌作用。例如,a)并非所有诱导皮肤增生的化合物都是皮肤肿瘤促进剂,b)诱导“再生”细胞增殖的药物似乎对肿瘤的诱导作用与具有直接促有丝分裂作用的药物不同,并且c)致癌活性许多非诱变剂的数量取决于该剂的连续施用。另外,具有高细胞增殖率的组织没有更高的患癌风险。因此,在细胞增殖和致癌之间不存在简单的关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号